These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 36447056
1. Genetic aetiology of Down syndrome birth: novel variants of maternal DNMT3B and RFC1 genes increase risk of meiosis II nondisjunction in the oocyte. Halder P, Pal U, Ganguly A, Ghosh P, Ray A, Sarkar S, Ghosh S. Mol Genet Genomics; 2023 Jan; 298(1):293-313. PubMed ID: 36447056 [Abstract] [Full Text] [Related]
2. The etiology of Down syndrome: Maternal MCM9 polymorphisms increase risk of reduced recombination and nondisjunction of chromosome 21 during meiosis I within oocyte. Pal U, Halder P, Ray A, Sarkar S, Datta S, Ghosh P, Ghosh S. PLoS Genet; 2021 Mar; 17(3):e1009462. PubMed ID: 33750944 [Abstract] [Full Text] [Related]
3. Risk of Down syndrome birth: Consanguineous marriage is associated with maternal meiosis-II nondisjunction at younger age and without any detectable recombination error. Ray A, Oliver TR, Halder P, Pal U, Sarkar S, Dutta S, Ghosh S. Am J Med Genet A; 2018 Nov; 176(11):2342-2349. PubMed ID: 30240118 [Abstract] [Full Text] [Related]
4. Etiology of Down syndrome: Evidence for consistent association among altered meiotic recombination, nondisjunction, and maternal age across populations. Ghosh S, Feingold E, Dey SK. Am J Med Genet A; 2009 Jul; 149A(7):1415-20. PubMed ID: 19533770 [Abstract] [Full Text] [Related]
6. New insights into human nondisjunction of chromosome 21 in oocytes. Oliver TR, Feingold E, Yu K, Cheung V, Tinker S, Yadav-Shah M, Masse N, Sherman SL. PLoS Genet; 2008 Mar 14; 4(3):e1000033. PubMed ID: 18369452 [Abstract] [Full Text] [Related]
7. The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms. Antonarakis SE, Petersen MB, McInnis MG, Adelsberger PA, Schinzel AA, Binkert F, Pangalos C, Raoul O, Slaugenhaupt SA, Hafez M. Am J Hum Genet; 1992 Mar 14; 50(3):544-50. PubMed ID: 1347192 [Abstract] [Full Text] [Related]
8. Understanding etiology of chromosome 21 nondisjunction from gene × environment models. Halder P, Pal U, Ganguly A, Ghosh P, Ray A, Sarkar S, Ghosh S. Sci Rep; 2021 Nov 17; 11(1):22390. PubMed ID: 34789805 [Abstract] [Full Text] [Related]
9. Telomere length is associated with types of chromosome 21 nondisjunction: a new insight into the maternal age effect on Down syndrome birth. Ghosh S, Feingold E, Chakraborty S, Dey SK. Hum Genet; 2010 Apr 17; 127(4):403-9. PubMed ID: 20063167 [Abstract] [Full Text] [Related]
10. Nondisjunction in trisomy 21: origin and mechanisms. Petersen MB, Mikkelsen M. Cytogenet Cell Genet; 2000 Apr 17; 91(1-4):199-203. PubMed ID: 11173856 [Abstract] [Full Text] [Related]
11. Chromosome 21 non-disjunction and Down syndrome birth in an Indian cohort: analysis of incidence and aetiology from family linkage data. Ghosh S, Bhaumik P, Ghosh P, Dey SK. Genet Res (Camb); 2010 Jun 17; 92(3):189-97. PubMed ID: 20667163 [Abstract] [Full Text] [Related]
12. The association between maternal occupation and down syndrome: A report from the national Down syndrome project. Keen C, Hunter JE, Allen EG, Rocheleau C, Waters M, Sherman SL. Int J Hyg Environ Health; 2020 Jan 17; 223(1):207-213. PubMed ID: 31519426 [Abstract] [Full Text] [Related]
13. Maternal risk for down syndrome and polymorphisms in the promoter region of the DNMT3B gene: a case-control study. Jaiswal SK, Sukla KK, Kumari N, Lakhotia AR, Kumar A, Rai AK. Birth Defects Res A Clin Mol Teratol; 2015 Apr 17; 103(4):299-305. PubMed ID: 25656965 [Abstract] [Full Text] [Related]
14. The association of low socioeconomic status and the risk of having a child with Down syndrome: a report from the National Down Syndrome Project. Hunter JE, Allen EG, Shin M, Bean LJ, Correa A, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL. Genet Med; 2013 Sep 17; 15(9):698-705. PubMed ID: 23558253 [Abstract] [Full Text] [Related]
15. Preconception folic acid supplementation and risk for chromosome 21 nondisjunction: a report from the National Down Syndrome Project. Hollis ND, Allen EG, Oliver TR, Tinker SW, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Freeman SB, Sherman SL, Bean LJ. Am J Med Genet A; 2013 Mar 17; 161A(3):438-44. PubMed ID: 23401135 [Abstract] [Full Text] [Related]
16. Trisomy 21 (Down syndrome): studying nondisjunction and meiotic recombination by using cytogenetic and molecular polymorphisms that span chromosome 21. Stewart GD, Hassold TJ, Berg A, Watkins P, Tanzi R, Kurnit DM. Am J Hum Genet; 1988 Feb 17; 42(2):227-36. PubMed ID: 2893544 [Abstract] [Full Text] [Related]
17. Molecular analysis of nondisjunction in Down syndrome patients with and without atrioventricular septal defects. Zittergruen MM, Murray JC, Lauer RM, Burns TL, Sheffield VC. Circulation; 1995 Nov 15; 92(10):2803-10. PubMed ID: 7586245 [Abstract] [Full Text] [Related]
18. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Allen EG, Freeman SB, Druschel C, Hobbs CA, O'Leary LA, Romitti PA, Royle MH, Torfs CP, Sherman SL. Hum Genet; 2009 Feb 15; 125(1):41-52. PubMed ID: 19050929 [Abstract] [Full Text] [Related]
19. Association between maternal age and meiotic recombination for trisomy 21. Lamb NE, Yu K, Shaffer J, Feingold E, Sherman SL. Am J Hum Genet; 2005 Jan 15; 76(1):91-9. PubMed ID: 15551222 [Abstract] [Full Text] [Related]